Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katy M Roach

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
European Journal of Pharmacology|March 6, 2025
TGFβ1 generates a pro-fibrotic proteome in human lung parenchyma that is sensitive to pharmacological interventionColleen B Maxwell, Panayiota Stylianou, Hilary Marshall, et al.
American Journal of Respiratory Cell and Molecular Biology|January 7, 2017
Inhibition of the K<sub>Ca</sub>3.1 Channel Alleviates Established Pulmonary Fibrosis in a Large Animal ModelLouise Organ, Barbara Bacci, Emmanuel Koumoundouros, et al.
British Journal of Pharmacology|March 31, 2021
TGFβ1 induces resistance of human lung myofibroblasts to cell death via down-regulation of TRPA1 channelsHarvinder S Virk, Michael S Biddle, Dawn T Smallwood, et al.
Journal of Medicinal Chemistry|July 12, 2021
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent InhibitorsGiuseppe Campiani, Caterina Cavella, Jeremy D Osko, et al.
The Lancet. Respiratory Medicine|August 19, 2022
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association studyRichard J Allen, Justin M Oldham, David A Jenkins, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
European Journal of Pharmacology|March 6, 2025
TGFβ1 generates a pro-fibrotic proteome in human lung parenchyma that is sensitive to pharmacological interventionColleen B Maxwell, Panayiota Stylianou, Hilary Marshall, et al.
American Journal of Respiratory Cell and Molecular Biology|January 7, 2017
Inhibition of the K<sub>Ca</sub>3.1 Channel Alleviates Established Pulmonary Fibrosis in a Large Animal ModelLouise Organ, Barbara Bacci, Emmanuel Koumoundouros, et al.
British Journal of Pharmacology|March 31, 2021
TGFβ1 induces resistance of human lung myofibroblasts to cell death via down-regulation of TRPA1 channelsHarvinder S Virk, Michael S Biddle, Dawn T Smallwood, et al.
Journal of Medicinal Chemistry|July 12, 2021
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent InhibitorsGiuseppe Campiani, Caterina Cavella, Jeremy D Osko, et al.
The Lancet. Respiratory Medicine|August 19, 2022
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association studyRichard J Allen, Justin M Oldham, David A Jenkins, et al.
Pageof 2